Hotchkis & Wiley Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $8.27M | Buy |
|
|||||
|
2023
Q1 | $7.01M | Buy |
|
|||||
|
2022
Q4 | $7.21M | Buy |
|
|||||
|
2022
Q3 | $9.28M | Buy |
|
|||||
|
2022
Q2 | $9.83M | Sell |
|
|||||
|
2022
Q1 | $10.3M | Buy |
|
|||||
|
2021
Q4 | $8.53M | Buy |
|
|||||
|
2021
Q3 | $4.45M | Sell |
|
|||||
|
2021
Q2 | $5.66M | Buy |
|
|||||
|
2021
Q1 | $3.65M | Sell |
|
|||||
|
2020
Q4 | $3.5M | Buy |
|